前往化源商城

炔诺肟酯

炔诺肟酯结构式
炔诺肟酯结构式
品牌特惠专场
常用名 炔诺肟酯 英文名 Norgestimate
CAS号 35189-28-7 分子量 369.497
密度 1.2±0.1 g/cm3 沸点 497.9±45.0 °C at 760 mmHg
分子式 C23H31NO3 熔点 216ºC
MSDS 中文版 美版 闪点 254.9±28.7 °C
符号 GHS07 GHS08
GHS07, GHS08
信号词 Warning

Types of combined oral contraceptives used by US women.

Contraception 86(6) , 659-65, (2012)

We sought to estimate the prevalence of types of combined oral contraceptives (COCs) used among US women.We analyzed interview-collected data from 12,279 women aged 15-44 years participating in the National Survey of Family Growth, 2006-2010. Analyses focused...

Mechanosensitive ATP release from hemichannels and Ca²⁺ influx through TRPC6 accelerate wound closure in keratinocytes.

J. Cell Sci. 127(Pt 19) , 4159-71, (2014)

The study aimed to investigate the effect of inhibition of poly(ADP-ribose) polymerase-1 (PARP-1) activity on tau phosphorylation in HEK293/tau441 cells and its mechanism. HEK293/tau441 cells were treated with 3-aminobenzamide (3-AB), a PARP-1 inhibitor, at d...

Progestins in preventive hormone therapy. Including pharmacology of the new progestins, desogestrel, norgestimate, and gestodene: are there advantages?

Obstet. Gynecol. Clin. North Am. 21(2) , 299-319, (1994)

Clofarabine was the latest new drug to be approved, in 2004, for relapsed or refractory acute lymphoblastic leukaemia (ALL). To investigate its value in the frontline treatment of ALL we applied clofarabine 5 × 40 mg/m(2) in combination with pegylated asparag...

Clinical aspects of three new progestogens: desogestrel, gestodene, and norgestimate.

Am. J. Obstet. Gynecol. 160(5 Pt 2) , 1296-300, (1989)

Three new 19-nortestosterone progestogens, which are chemically related to levonorgestrel, are now clinically available in combination oral contraceptives in Europe. Desogestrel and norgestimate must be transformed to metabolites for all or part of their biol...

The new era in oral contraception: pills containing gestodene, norgestimate, and desogestrel.

Obstet. Gynecol. Surv. 47(11) , 777-82, (1992)

The latest advance in the 30-year evolution of oral contraceptives (OCs) is the development of three new progestogens: desogestrel, norgestimate, and gestodene. These three new agents are derivatives of levonorgestrel, a gonane hormone, and have been used to ...

Desogestrel, norgestimate, and gestodene: the newer progestins.

Ann. Pharmacother. 29(7-8) , 736-42, (1995)

To review and compare the newer progestins desogestrel, norgestimate, and gestodene with regard to chemistry, pharmacokinetics, efficacy, and tolerability.Primary literature on desogestrel, norgestimate, and gestodene was identified from a comprehensive MEDLI...

A review of post-marketing safety and surveillance data for oral contraceptives containing norgestimate and ethinyl estradiol.

Int. J. Fertil. Womens. Med. 42(4) , 230-9, (1997)

Pharmacokinetics and pharmacodynamics of a transdermal contraceptive patch and an oral contraceptive.

J. Clin. Pharmacol. 47(4) , 497-509, (2007)

This open-label, randomized, 2-way crossover study characterized the pharmacokinetics and pharmacodynamics of a transdermal contraceptive patch and a norgestimate-containing oral contraceptive. Healthy women (n = 34) applied a patch once weekly for 3 consecut...

Adolescents' experiences using the contraceptive patch versus pills.

J. Pediatr. Adolesc. Gynecol. 24(4) , 197-203, (2011)

To compare use of the weekly transdermal contraceptive patch (patch) with daily combined hormonal contraceptive pills (pills) in adolescents.Prospective longitudinal study of adolescents' self-selected (non-randomized) use of the patch or pills.Urban, univers...

The contraceptive patch in relation to ischemic stroke and acute myocardial infarction.

Pharmacotherapy 27(2) , 218-20, (2007)

To compare rates of stroke and acute myocardial infarction in users of the Ortho EVRA contraceptive patch with these rates in users of norgestimate-containing oral contraceptives (OCs) with 35 microg of ethinyl estradiol.Retrospective, population-based, epide...